Article info
Ethics
Research
Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
- Correspondence to Dr Jennifer E Miller; jennifer.miller{at}nyumc.org
Citation
Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
Publication history
- Received May 26, 2017
- Revised October 25, 2017
- Accepted October 31, 2017
- First published December 5, 2017.
Online issue publication
January 10, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/